The loss of PDLIM2 in alveolar macrophages leads to recruitment and transformation of mononuclear macrophages from blood circulation into lung macrophages, thereby promoting tumor activation within alveolar macrophages while impairing cytotoxic T lymphocyte-mediated phagocytosis, ultimately facilitating tumor development. The gene discussed is PDLIM2; the disease is neoplasm.